carmegliptin

a hypoglycemic agent that inhibits dipeptidyl peptidase IV; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Type 2 Diabetes Mellitus (MODY) 02/01/2010 - "Discovery of carmegliptin: a potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes."
2.	Breast Neoplasms (Breast Cancer) 12/01/2010 - "Breast cancer resistance protein (Bcrp) is not expected to be involved in the transport of carmegliptin since in vitro carmegliptin was not significantly transported by this transporter. "

1.	Dipeptidyl-Peptidase IV Inhibitors
2.	Proteins (Proteins, Gene)